Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Helix BioMedix Inc.

Latest From Helix BioMedix Inc.

Helix Biomedix to focus on commercialisation, loses CSO

Helix Biomedix of the US is shifting its focus from expanding its libraries of bioactive peptides and small molecules to "intensifying" efforts to commercialise them. As a result, the company's CSO Dr Timothy Falla is leaving his post.

Do VCs Prefer Public Biotechs?

Private biotechs have run into another complication in seeking venture financing as of late: the fact that so many public, and more mature, biotechs have fallen into VCs' price range.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Helix BioMedix Inc.
  • Senior Management
  • R. Stephen Beatty, Pres. & CEO
    David Kirske, CFO
    Robin L Carmichael, VP, COO
  • Contact Info
  • Helix BioMedix Inc.
    Phone: (425) 402-8400
    22122 20th Ave. SE
    Bothell, WA 98021